[Federal Register Volume 64, Number 183 (Wednesday, September 22, 1999)]
[Notices]
[Pages 51327-51328]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-24597]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Psychopharmacologic Drugs Advisory Committee; Amendment of Notice
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
amendment to the notice of meeting of the Psychopharmacologic Drugs
Advisory Committee. This meeting was announced in the Federal Register
of August 26, 1999 (64 FR 46687). The
[[Page 51328]]
amendment is being made to cancel the entire session on October 7,
1999. This meeting will be open to the public. There are no other
changes.
FOR FURTHER INFORMATION CONTACT: Sandra L. Titus, Center for Drug
Evaluation and Research (HFD-21), Food and Drug Administration, 5600
Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093)
Rockville, MD 20857, 301-827-7001, or e-mail tituss@cder.fda.gov'',
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area) code 12544. Please call the
Information Line for up-to-date information on this meeting.
SUPPLEMENTARY INFORMATION: In the Federal Register of August 26, 1999
(64 FR 46687), FDA announced that a meeting of the Psychopharmacologic
Drugs Advisory Committee would be held on October 7 and 8, 1999. On
page 46687, beginning in the first column, the Date and Time, Agenda,
and Procedure portions of this meeting are amended to read as follows:
Date and Time: The meeting will be held October 8, 1999, 8 a.m. to
4:30 p.m.
Agenda: On October 8, 1999, the committee will consider the safety
and efficacy of new drug application 19-839/S-026, Zoloft,
(sertraline hydrochloride, Pfizer Pharmaceuticals) proposed to treat
posttraumatic stress disorder.
Procedure: Interested persons may present data, information, or
views, orally or in writing, on issues pending before the committee.
Written submissions may be made to the contact person by October 1,
1999. Oral presentations from the public will be scheduled between
approximately 1 p.m. and 2 p.m. Time allotted for each presentation may
be limited. Those desiring to make formal oral presentations should
notify the contact person before October 1, 1999, and submit a brief
statement of the general nature of the evidence or arguments they wish
to present, the names and addresses of proposed participants, and an
indication of the approximate time requested to make their
presentation.
Dated: September 13, 1999.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 99-24597 Filed 9-21-99; 8:45 am]
BILLING CODE 4160-01-F
